Pan-European generic and OTC pharmaceutical manufacturer serving 100+ million patients
Zentiva is a mid-size pharma manufacturer with 5,000+ employees across 4 owned plants and external partners, reaching over 100 million patients in Europe. The tech stack is enterprise-heavy (SAP ecosystem, HANA, Veeva, Tracelink), reflecting regulated manufacturing operations; no active adopting/replacing signals suggest a stable infrastructure baseline. Hiring is anchored in manufacturing (45 roles) and sales (32), with projects clustered around GxP compliance, yield optimization, and production planning—typical for a company scaling organically under PE ownership while managing regulatory burden.
Notable leadership hires: Chief Financial Officer
Zentiva develops, manufactures, and distributes generic and over-the-counter medicines across Europe, covering therapeutic areas including cardiology, diabetes, oncology, respiratory, and central nervous system disorders. The company operates 4 wholly owned manufacturing facilities supplemented by a network of external partners to ensure supply security and meet demand from over 100 million patients across European markets. Privately equity-backed, the organization is pursuing a 5-year growth plan combining organic expansion and inorganic acquisition. Operations span 16+ countries, with significant employment in manufacturing, sales, quality, and finance functions.
Zentiva runs SAP (SD, MM, R/3, HANA, Fiori), LIMS, Veeva, Tracelink, GCP, Tableau, Power BI, and Adobe Creative Suite. The stack is heavily weighted toward enterprise resource planning and pharma-specific compliance and supply-chain tools.
Zentiva is headquartered in Prague, Czechia, with 4 owned manufacturing sites. The company hires across 16 European countries including Romania, Bulgaria, Poland, Serbia, Croatia, Hungary, Germany, and Slovakia, plus India and the United Kingdom.
Other companies in the same industry, closest in size